Health care stocks leaned lower premarket Monday with the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) down 2.1% recently.

ADMA Biologics (ADMA) said it doesn't expect the latest US tariffs on foreign goods and services to have any impact on its supply chain or production operations. Shares of ADMA Biologics fell past 4% pre-bell.